近岸蛋白: 关于2025年半年度计提资产减值准备的公告

Group 1 - The company reported a credit impairment loss of 82.76 thousand yuan, with accounts receivable bad debt loss of 90.43 thousand yuan and other receivables bad debt recovery of 7.67 thousand yuan [2] - The company recognized an asset impairment loss of 1,812.77 thousand yuan, entirely attributed to inventory write-downs [2] - The total impact of the impairment provisions on the company's consolidated profit amounted to 1,730.01 thousand yuan [2] Group 2 - The impairment provisions were made in accordance with the accounting policies and standards to reflect the financial status and operating results as of June 30, 2025 [1] - The impairment losses were not audited by the accounting firm, and investors are advised to be cautious regarding investment risks [2]